SURG

Value Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 9.6 M10.58 M11.52 M18.68 M — Gross profit -11.23 M-2.94 M-2.65 M-2.6 M — Operating expenses 7.15 M4.64 M4.16 M4.35 M — Selling/general/admin expenses 7.15 M4.64 M4.16 M4.35 M — Research & development ———— — Operating income -18.38 M-7.58 M-6.81 M-6.95 M — Non-Operating Income, Total -1.71 M-55.39 K-272.3 K-539.16 K — Interest expense, net of interest capitalized 554.2 K238.87 K212.42 K424.67 K — Non-Operating Income, excl. Interest Expenses -2.26 M-301.4 K-484.36 K-964.18 K — Unusual income/expense -2397 140-355355 — Pretax income -20.09 M-7.64 M-7.08 M-7.49 M — Equity in earnings ———— — Taxes -100 K000 — Non-controlling/minority interest -172.56 K-209-209-227 — After tax other income/expense ———— — Net income before discontinued operations -19.81 M-7.64 M-7.08 M-7.49 M — Discontinued operations —0—— — Net income -19.81 M-7.64 M-7.08 M-7.49 M — Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -19.81 M-7.64 M-7.08 M-7.49 M — Basic earnings per share (Basic EPS) -1.07-0.38-0.36-0.38 — Diluted earnings per share (Diluted EPS) -1.07-0.38-0.36-0.38 — Average basic shares outstanding 19.12 M20.07 M19.89 M19.84 M — Diluted shares outstanding 19.12 M20.07 M19.89 M19.84 M — EBITDA -17.67 M-7.49 M-6.74 M-6.92 M — EBIT -18.38 M-7.58 M-6.81 M-6.95 M — Cost of revenue 20.83 M13.52 M14.17 M21.28 M — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 709.62 K86.12 K66.36 K26.84 K —